Bristol Myers Squibb is set to invest $2.3 billion in a new 600,000-square-foot manufacturing facility at Generation Park in Houston, creating nearly 500 jobs. This investment reflects the city’s expanding life sciences sector and follows a similar $6.5 billion project from Eli Lilly in the region. The facility, expected to become operational by 2030, will have the capacity to produce various types of medicines and represent a strategic effort to bolster domestic manufacturing capabilities. Houston’s strong research institutions, workforce training programs, and supportive business environment have made it an attractive destination for life sciences investments, with local leaders emphasizing the region’s potential in advanced manufacturing.
Disclaimer: This summary is written by AI, which can make mistakes. Please follow up on any news information from additional sources.
Link to original article source: https://www.houston.org/news/bristol-myers-squibb-facility/
